Showing results (601-610 of 776) with videos related to
Sort By:
Pageof 78
Journal of the American Academy of Dermatology|September 21, 2011
Long-term safety experience of ustekinumab in patients with moderate-to-severe psoriasis (Part I of II): results from analyses of general safety parameters from pooled Phase 2 and 3 clinical trialsMark Lebwohl, Craig Leonardi, Christopher E M Griffiths, et al.American Journal of Clinical Dermatology|September 30, 2018
Effect of Age of Onset of Psoriasis on Clinical Outcomes with Systemic Treatment in the Psoriasis Longitudinal Assessment and Registry (PSOLAR)Sanminder Singh, Robert E Kalb, Elke M G J de Jong, et al.Journal of the American Academy of Dermatology|February 8, 2020
Efficacy and safety of apremilast in patients with moderate to severe plaque psoriasis of the scalp: Results of a phase 3b, multicenter, randomized, placebo-controlled, double-blind studyAbby S Van Voorhees, Linda Stein Gold, Mark Lebwohl, et al.Digestive Diseases and Sciences|May 29, 2024
The Burden of Work Productivity and Activity Impairment in Patients with Psoriasis, Psoriatic Arthritis, Ulcerative Colitis, and Crohn's DiseaseJud C Janak, Anita M Loughlin, Page C Moore, et al.Journal of Cutaneous Medicine and Surgery|May 16, 2006
Clinical efficacy of efalizumab in patients with chronic plaque psoriasis: results from three randomized placebo-controlled Phase III trials: part IDavid M Pariser, Kenneth B Gordon, Kim A Papp, et al.Journal of Drugs in Dermatology : JDD|August 7, 2025
Two-Year Treatment Persistence of Guselkumab vs Other Biologics in Plaque Psoriasis PatientsBruce E Strober, Jud C Janak, Timothy Fitzgerald, et al.Acta Dermato-Venereologica|September 12, 2024
Notalgia Paresthetica Dermatologist Report of Symptom Burden and Treatment: Results from a Physician SurveyBrian S Kim, Sonja Ständer, Kenji Kabashima, et al.The Journal of Clinical and Aesthetic Dermatology|October 24, 2024
Improvement in Patient-reported Symptoms and Satisfaction with Tildrakizumab in a Real-world Study in Patients with Moderate-to-severe Plaque PsoriasisJuan Gabriel Vasquez, Jayme M Heim, Tina Bhutani, et al.Journal of Drugs in Dermatology : JDD|August 27, 2020
Fixed Combination Calcipotriene and Betamethasone Dipropionate (Cal/BD) Foam for Beyond-Mild Psoriasis: A Possible Alternative to Systemic MedicationLeon Kircik, Linda Stein Gold, Joyce Teng, et al.Journal of Visualized Experiments : Jove|July 30, 2013
The Goeckerman regimen for the treatment of moderate to severe psoriasisRishu Gupta, Maya Debbaneh, Daniel Butler, et al.Pageof 78